Flygt H, Soderlund S, Stentoft J, Richter J, et al. Long-term tolerability and efficacy after initial PegIFN-alpha addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study. Eur J Haematol 2021;107:617-623.
PMID: 34418168